Fig. 7

Serum CXCL10 and SCC-Ag levels of the cervical cancer patients during the treatment, who had partial response after treatment. Dynamic changes in serum CXCL10 and SCC-Ag levels (shown as concentration) (A, B). Blood samples were collected from patients prior to each time of treatment. C0 (prior to the first cycle of treatment), C1 (prior to the second cycle of treatment) and C2(prior to the third cycle of treatment). Variations in serum CXCL10 and SCC-Ag levels after two cycles of treatment (C, D). Consistent and Inconsistent frequency in changes of serum CXCL10 and SCC-Ag levels after two cycles of treatment with the partial response (E)